Business Practice

Ukrainian drug discovery has been disrupted by war. We spoke to leaders of its largest player about the domestic industry’s past, present, and future.

The Medicine Maker is proud to present the Power List 2022 and the inaugural Company of the Year Awards

What do companies need to consider when developing next-gen medicines for rare diseases?

We sat down to talk shop with Novo Nordisk Executive Vice President Ludovic Helfgott

One decade behind the EU, biosimilars are arriving in the US. What can we expect? Jeff Baldetti from Cardinal Health has a few ideas.

Medicines Patent Pool has joined forces with over 30 generic manufacturers to help ensure access to anti-COVID-19 medicines for all.

The Medicine Maker’s round up of the top news stories in the pharma industry in March.

We find out how technology is enabling remote inspections in the pharma industry.

Reconfigure. Redefine. Why modular cleanroom furniture is essential for a changing pharmaceutical market.

That which we call rosaimab by any other name would find regulatory approval and commercial success. Or would it?